Protein expression profiling of cytokines and cytokine receptors on purified chronic lymphocytic leukemia cells from patients with favourable prognostic indicators
- 1 January 2008
- journal article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 49 (4) , 751-756
Abstract
Chronic lymphocytic leukemia (CLL) cells rapidly undergo apoptosis when cultured in vitro, which contrasts with their prolonged survival in vivo. Multiple cytokines and cytokine receptors are believed to work together to regulate the survival of CLL cells. The aim of the current study was to measure the endogenous expression and secretion of cytokines and cytokine receptors in CLL cells when exogenous cytokines are minimized. We demonstrated that the intracellular and secreted levels of 174 cytokines and cytokine receptors of purified CLL B-cells were not significantly different from those of normal B-cells except for the secreted levels of IL-6 and eotaxin. IL-6 was 3.0 times lower (p = 0.038) whereas eotaxin was 2.2 times higher (p = 0.027) in CLL conditioned medium than in normal B-cell conditioned medium. Our results suggest that, except for IL-6 and eotaxin, CLL B-cells and their normal counterparts produce and secrete similar amounts of cytokines and cytokine receptors in vitro.Keywords
This publication has 29 references indexed in Scilit:
- Pathophysiologic mechanisms of chronic lymphocytic leukemia and their application to therapyExperimental Hematology, 2007
- Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an “angiogenic switch”Leukemia Research, 2007
- The Clinical and Biologic Importance of Neovascularization and Angiogenic Signaling Pathways in Chronic Lymphocytic LeukemiaSeminars in Oncology, 2006
- Microenvironmental Interactions and Survival of CLL B-cellsLeukemia & Lymphoma, 2004
- In vitro production of anti‐RBC antibodies and cytokines in chronic lymphocytic leukemiaAmerican Journal of Hematology, 2002
- Expression and Production of Interleukin 4 in B-Cell Chronic Lymphocytic LeukaemiaLeukemia & Lymphoma, 2001
- Interleukin-10 Inhibits theIn vitroProliferation of Human Activated Leukemic CD5+B-CellsLeukemia & Lymphoma, 1998
- Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia.Journal of Experimental Medicine, 1993
- Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression.Journal of Experimental Medicine, 1992
- TUMOUR NECROSIS FACTOR AS AN AUTOCRINE TUMOUR GROWTH FACTOR FOR CHRONIC B-CELL MALIGNANCIESThe Lancet, 1988